High materiality8/10
Viking Therapeutics price target raised to $120 from $100 at Oppenheimer
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises VKTX target to $120 from $100. Current price is $38.56. Price change since signal: +2.18. The setup implies substantial upside.
- Target to 120 from 100; price 38.56; upside implied
Key facts
- 01
Target: $120
- 02
Posted price: $38.56
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.